Assignee
SEQUOIA PHARMACEUTICALS INC
US·11 granted patents·7 pending applications·35 citations·filing 2003–2019
Top patents by PatentIndex Score
18 records- 0187US7981929B2Benzofuran derived HIV protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2008·Granted Jul 19, 2011·5 cites·35 claims
- 0282US8048871B2Compositions and methods for inhibiting cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2007·Granted Nov 1, 2011·5 cites·25 claims
- 0380US7109230B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2003·Granted Sep 19, 2006·9 cites·26 claims
- 0476US7378441B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2005·Granted May 27, 2008·4 cites·26 claims
- 0572US8791157B25-substituted benzofurans as inhibitors of cytochrome P450 2D6SEQUOIA PHARMACEUTICALS INC·Filed 2013·Granted Jul 29, 2014·2 cites·13 claims
- 0672US7807845B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2005·Granted Oct 5, 2010·3 cites·17 claims
- 0772US7151163B2Antiviral agents for the treatment, control and prevention of infections by coronavirusesSEQUOIA PHARMACEUTICALS INC·Filed 2004·Granted Dec 19, 2006·6 cites·8 claims
- 0870US9540354B2Diamide inhibitors of cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·1 cites·22 claims
- 0966US2006258737A1Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1062US2020289456A1Methods for inhibiting tumors and drug resistanceSEQUOIA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1161US2006293286A1Resistant-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1260US9604952B2Compositions and methods for inhibiting cytochrome P450 2D6SEQUOIA PHARMACEUTICALS INC·Filed 2014·Granted Mar 28, 2017·0 cites·10 claims
- 1358US9233952B2Compositions and methods for inhibiting cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2013·Granted Jan 12, 2016·0 cites·21 claims
- 1454US2017354636A1Methods for inhibiting tumors and drug resistanceSEQUOIA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1552US9849107B2Compositions and methods for inhibiting cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·0 cites·20 claims
- 1651US2007185027A1Antiviral agents for the treatment, control and prevention of infections by coronavirusesSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1744US2018256534A1Ketamine and cytochrome p 450 inhibitor combinationsSEQUOIA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1840US2015284352A1Methods for inhibiting drug degradationSEQUOIA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →